SR1555 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective agonist for the nuclear receptor related 1 (Nurr1) protein, which plays a crucial role in regulating inflammation and cell survival. Researchers are exploring its use in targeting cancer cells, particularly in cases where Nurr1 activation can induce apoptosis or inhibit tumor growth. Additionally, SR1555 is being studied for its neuroprotective properties, with potential applications in neurodegenerative diseases such as Parkinson's. Its ability to modulate inflammatory pathways also makes it a candidate for treating inflammatory disorders. Ongoing preclinical studies aim to further elucidate its efficacy and safety profile for these applications.